Beta-Lactams in Critically Ill Children: Time to Step Up Our Game?

Pediatr Crit Care Med. 2022 Jul 1;23(7):568-570. doi: 10.1097/PCC.0000000000002982. Epub 2022 Jul 1.

Authors

Céline Thibault^{1

2}, Amélie Marsot³, Julie Autmizguine^{2

4}

Affiliations

¹ Division of Critical Care Medicine, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada.
² Department of Pharmacology and Physiology, Université de Montréal, Montreal, QC, Canada.
³ Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
⁴ Division of Infectious Diseases, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada.

PMID: 35797574
DOI: 10.1097/PCC.0000000000002982

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Child
Critical Illness* / therapy
Humans
Infusions, Intravenous
beta-Lactams* / therapeutic use

Substances

Anti-Bacterial Agents
beta-Lactams